Beyaz

Thursday, November 11, 2010 - 16:08

Blood clots, gallbladder disease, heart attack and stroke are four of the main adverse side effects thousands of women, their doctors, and legal representatives claim are caused by the drugs Yaz and Yasmin and their generic equivalents. In many pharmaceutical cases, when massive evidence piles up in the form of lawsuits for a company, the company in question often removes the drug from the market and halts its distribution.

Wednesday, November 10, 2010 - 12:58

Thousands of Yaz, Yasmin and Ocella lawsuits are pending against the pharmaceutical company Bayer. With all the negative attention the company has received over their birth control product line, Bayer has yet to cease its contraceptive production and marketing.

Instead, Bayer has taken the same controversial ingredients used in Yaz and Yasmin, added folic acid, packaged them in a new container with a new name, and released them to the U.S. market with immediate FDA approval. The new pill, Beyaz, was released in October 2010 in U.S. and international markets.

Friday, October 29, 2010 - 11:53

In May of 2010with thousands of lawsuits pending against Bayer for birth control drugs Yaz, Yasmin, and Ocellathe FDA found it suitable to approve Bayer’s new pill, Natazia. In September of 2010, with over 4,000 lawsuits filed, the FDA approved the release of Beyaz, another birth control pill with the exact same active ingredients as the contested Yaz and Yasmin. Natazia contains a different formulation of ingredients, but still may draw fire as the litigation proceeds.

Tuesday, October 26, 2010 - 11:53

In late September 2010, the FDA approved a “new” birth control pill called Beyaz. The lawsuit-beleaguered pharmaceutical company Bayer manufactures the drug. Beyaz is short for “Beyond Yaz,” in reference to Yaz, an earlier form of the same birth control formula. Beyaz includes a folate supplement in the pill. Beyaz could prove instrumental in Bayer’s undoing if more than 4,000 lawsuits against Bayer meet with success.

Wednesday, October 13, 2010 - 12:29

In a questionable move by Bayer and the FDA, a vitamin-supplemented version of Yaz has been released on the market, even while thousands of lawsuits alleging the dangers of severe side effects and death are pending against the company.

Wednesday, October 13, 2010 - 12:18

In late September of 2010, Bayer announced the release of a new FDA-approved birth control pill containing the same contentious ingredient as Yaz and Yasmin. Lawsuits against the company over alleged dangerous side effects - including pulmonary embolism and deep vein thrombosis - have increased to over 3,000 plaintiffs.

Wednesday, October 13, 2010 - 08:48

In a startling move, the FDA approved Beyaz, a birth control pill with the same controversial ingredients as lawsuit embroiled Yaz, Yasmin, and Ocella. The difference between those pills and Beyaz is 451 mcg of levomefolate calcium, otherwise known as folic acid. Critics of Bayer and the FDA claim that the company has released Beyaz as a way to boost sales, even with thousands of lawsuits pending against the company.

Tuesday, October 5, 2010 - 14:00

Despite previous concerns of harmful side effects caused by the use of Yaz and Yasmin, the U.S. Food and Drug Administration has granted Bayer Healthcare Pharmaceuticals drug approval for the new birth control pill Beyaz.